Implandata

Glaucoma monitoring implant receives CE markAn implantable glaucoma sensor has received CE mark approval for marketing in the European Union. The sensor (Eyemate, Implandata Ophthalmic Products) can provide frequent IOP readings, informing patients and their physicians about how the pressure changes by time of day and from one day to another.
IOP sensor successfully implanted in first patientImplandata Ophthalmic Products GmbH (Implandata) says it has successfully implanted its EyeMate intraocular pressure (IOP) sensor implant in a first patient in Europe undergoing keratoprosthesis surgery.
24-hour monitoring to revolutionize glaucoma careThe advent of 24-hour IOP monitoring will transform the care of patients with glaucoma and usher in a new era of personalizing IOP. 24-hour IOP monitoring set to revolutionize glaucoma research and clinical care.